X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14388) 14388
Book Review (3320) 3320
Publication (1046) 1046
Book / eBook (300) 300
Newsletter (151) 151
Book Chapter (53) 53
Magazine Article (32) 32
Conference Proceeding (23) 23
Dissertation (7) 7
Newspaper Article (5) 5
Paper (1) 1
Presentation (1) 1
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13231) 13231
humans (10912) 10912
male (6785) 6785
female (5857) 5857
animals (4752) 4752
gastrointestinal diseases - chemically induced (4457) 4457
middle aged (3726) 3726
adult (3258) 3258
aged (3227) 3227
abridged index medicus (2177) 2177
gastrointestinal diseases (2124) 2124
gastroenterology & hepatology (2015) 2015
anti-inflammatory agents, non-steroidal - adverse effects (1935) 1935
mice (1892) 1892
pharmacology & pharmacy (1879) 1879
gastrointestinal hemorrhage - chemically induced (1849) 1849
risk factors (1673) 1673
rats (1613) 1613
oncology (1322) 1322
analysis (1320) 1320
cancer (1209) 1209
treatment outcome (1179) 1179
disease models, animal (1123) 1123
nonsteroidal antiinflammatory drugs (1086) 1086
inflammation (1057) 1057
colitis (1030) 1030
aged, 80 and over (1008) 1008
research (1007) 1007
adolescent (928) 928
dose-response relationship, drug (924) 924
health aspects (878) 878
medicine & public health (876) 876
medicine, general & internal (872) 872
risk (854) 854
care and treatment (850) 850
time factors (847) 847
inflammatory bowel disease (838) 838
colitis - chemically induced (827) 827
aspirin - adverse effects (795) 795
rodents (779) 779
retrospective studies (745) 745
inflammatory-bowel-disease (736) 736
gastrointestinal system (701) 701
rheumatoid-arthritis (701) 701
therapy (699) 699
prevention (663) 663
medicine (662) 662
administration, oral (661) 661
drug therapy (652) 652
research article (648) 648
immunology (647) 647
aspirin (638) 638
gastroenterology and hepatology (638) 638
gastrointestinal tract (636) 636
anti-inflammatory agents, non-steroidal - therapeutic use (635) 635
double-blind (631) 631
digestive system (628) 628
chemotherapy (616) 616
microbiota (611) 611
double-blind method (607) 607
gastroenterology (606) 606
mice, inbred c57bl (604) 604
child (603) 603
ulcerative-colitis (582) 582
intestine (578) 578
antineoplastic agents - adverse effects (565) 565
article (561) 561
colon (558) 558
surgery (551) 551
prospective studies (546) 546
crohns-disease (545) 545
drug therapy, combination (533) 533
disease (531) 531
expression (530) 530
physiological aspects (526) 526
toxicology (516) 516
multidisciplinary sciences (502) 502
rats, sprague-dawley (497) 497
proteins (495) 495
nonsteroidal anti-inflammatory drugs (494) 494
complications and side effects (487) 487
toxicity (486) 486
clinical trials as topic (485) 485
gastrointestinal diseases - prevention & control (485) 485
physiology (481) 481
medical research (474) 474
rats, wistar (473) 473
drugs (465) 465
science (459) 459
young adult (455) 455
colon - pathology (452) 452
cardiovascular diseases - chemically induced (449) 449
studies (449) 449
drug administration schedule (447) 447
gene expression (439) 439
bacteria (438) 438
gastrointestinal-tract (434) 434
acute disease (431) 431
risk assessment (424) 424
gastric mucosa - drug effects (421) 421
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (256) 256
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Scarborough Hospital - General (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
St. Michael's Hospital - Stacks (6) 6
Lakeridge Health Sciences - Oshawa (5) 5
Online Resources - Online (3) 3
Providence Healthcare - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (2) 2
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
Toronto East General Hospital - Online (2) 2
Trillium Health Centre - Stacks (2) 2
Church Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Mt Sinai Hospital - Pathology (1) 1
Mt Sinai Hospital - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13667) 13667
German (276) 276
French (264) 264
Spanish (179) 179
Russian (109) 109
Italian (103) 103
Japanese (83) 83
Chinese (31) 31
Dutch (31) 31
Polish (29) 29
Danish (25) 25
Swedish (20) 20
Norwegian (17) 17
Czech (16) 16
Hungarian (14) 14
Portuguese (12) 12
Romanian (10) 10
Korean (9) 9
Croatian (6) 6
Hebrew (6) 6
Bulgarian (4) 4
Finnish (3) 3
Turkish (3) 3
Serbian (2) 2
Ukrainian (2) 2
Arabic (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 60, pp. 190 - 209
Journal Article
by Baigent, Colin and Bhala, N and Emberson, J and Merhi, A and Abramson, S and Arber, N and Baron, J.A and Bombardier, C and Cannon, C and Farkouh, M.E and FitzGerald, G.A and Goss, P and Halls, H and Hawk, E and Hawkey, C and Hennekens, C and Hochberg, M and Holland, L.E and Kearney, P.M and Laine, L and Lanas, A and Lance, P and Laupacis, A and Oates, J and Patrono, C and Schnitzer, T.J and Solomon, S and Tugwell, P and Wilson, K and Wittes, J and Adelowo, O and Aisen, P and Al-Quorain, A and Altman, R and Bakris, G and Baumgartner, H and Bresee, C and Carducci, M and Chang, D.-M and Chou, C.-T and Clegg, D and Cudkowicz, M and Doody, L and Miedany, Y.El and Falandry, C and Farley, J and Ford, L and Garcia-Losa, M and Gonzalez-Ortiz, M and Haghighi, M and Hala, M and Iwama, T and Jajic, Z and Kerr, D and Kim, H.-S and Kohne, C and Koo, B.-K and Martin, B and Meinert, C and Muller, N and Myklebust, G and Neustadt, D and Omdal, R and Ozgocmen, S and Papas, A and Patrignani, P and Pelliccia, F and Roy, V and Schlegelmilch, I and Umar, A and Wahlstrom, O and Wollheim, F and Yocum, S and Zhang, X.Y and Hall, E and McGettigan, P and Midgley, R and Moore, R.A and Philipson, R and Curtis, S and Reicin, A and Bond, J and Moore, A and Essex, M and Fabule, J and Morrison, B and Tive, L and Bhala, N and Davies, K and Emberson, J and Halls, H and Holland, L.E and Kearney, P.M and Merhi, A and Patrono, C and Wilson, K and Yau, F and Coxib Traditional NSAID Trialists and Coxib and traditional NSAID Trialists' (CNT) Collaboration
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9894, pp. 769 - 779
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 26, pp. 2519 - 2529
BACKGROUND The cardiovascular safety of celecoxib, as compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), remains uncertain. METHODS... 
MEDICINE, GENERAL & INTERNAL | PAIN | METAANALYSIS | OSTEOARTHRITIS | CLINICAL-TRIAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | Celecoxib - adverse effects | Naproxen - adverse effects | Ibuprofen - therapeutic use | Humans | Middle Aged | Male | Risk | Celecoxib - therapeutic use | Naproxen - therapeutic use | Cyclooxygenase 2 Inhibitors - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Intention to Treat Analysis | Kidney Diseases - chemically induced | Cardiovascular Diseases - mortality | Female | Aged | Cardiovascular Diseases - chemically induced | Ibuprofen - adverse effects | Gastrointestinal Diseases - chemically induced | Care and treatment | Safety and security measures | Naproxen | Ibuprofen | Dosage and administration | Arthritis | Celecoxib | Diagnosis | Cardiovascular diseases | Risk factors | Cardiovascular disease | Side effects | Nonsteroidal anti-inflammatory drugs | Pain management | Myocardial infarction | Fees & charges | Hemorrhage | Pain | Motivation | Analgesics | Safety | Drug dosages | Cerebral infarction | Statistical analysis | Anemia | Committees | FDA approval | Patients | Manuscripts | Nonsteroidal antiinflammatory drugs | Rheumatoid arthritis | Collaboration | Osteoarthritis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 405 - 417
We describe a series of Epstein Barr virus (EBV)-positive circumscribed, ulcerative lesions associated with various types of immunosuppression (IS). The study... 
Immunosuppression | Lymphoprolifeative | Epstein Barr virus | Mucocutaneous | SURGERY | CELL LYMPHOPROLIFERATIVE DISORDERS | OPTIMAL PRIMER SELECTION | NON-HODGKINS-LYMPHOMAS | immunosuppression | lymphoproliferative | PERIPHERAL-BLOOD | PATHOLOGY | CD8(+) T-CELLS | LYMPHOCYTE SUBPOPULATIONS | mucocutaneous | CYTOMEGALOVIRUS SEROPOSITIVITY | CHAIN-REACTION ANALYSIS | ELDERLY-PATIENTS | EPSTEIN-BARR-VIRUS | Immunohistochemistry | Recurrence | Humans | Middle Aged | Lymphoproliferative Disorders - chemically induced | Male | Skin Ulcer - immunology | Gastrointestinal Diseases - virology | T-Lymphocytes - virology | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Infections - therapy | T-Lymphocytes - drug effects | Aged, 80 and over | B-Lymphocytes - virology | Gastrointestinal Diseases - pathology | Skin Diseases, Infectious - virology | Skin Diseases, Infectious - pathology | Mouth Mucosa - immunology | Immune Tolerance | Gastrointestinal Diseases - therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | B-Lymphocytes - immunology | Mouth Mucosa - virology | Remission, Spontaneous | T-Lymphocytes - immunology | Oral Ulcer - pathology | Skin Diseases, Infectious - immunology | Age Factors | Oral Ulcer - immunology | Lymphoproliferative Disorders - immunology | Lymphoproliferative Disorders - therapy | Oral Ulcer - chemically induced | Mouth Mucosa - drug effects | In Situ Hybridization | Epstein-Barr Virus Infections - chemically induced | Polymerase Chain Reaction | Adult | Female | Skin Ulcer - virology | Skin Diseases, Infectious - therapy | Gastrointestinal Diseases - immunology | Skin Ulcer - therapy | Epstein-Barr Virus Infections - immunology | Gene Rearrangement, T-Lymphocyte | Lymphoproliferative Disorders - virology | Skin Diseases, Infectious - chemically induced | Treatment Outcome | Skin Ulcer - chemically induced | Genes, Immunoglobulin | B-Lymphocytes - drug effects | Oral Ulcer - therapy | Skin Ulcer - pathology | Immunosuppressive Agents - adverse effects | Aged | Oral Ulcer - virology | Gastrointestinal Diseases - chemically induced | Index Medicus | Muco-cutaneous | Lymphoproliferative
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2010, Volume 181, Issue 6, pp. 604 - 610
Journal Article